These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 31849926)

  • 1. Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs.
    Gotte G; Menegazzi M
    Front Immunol; 2019; 10():2626. PubMed ID: 31849926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribonucleases and their antitumor activity.
    Matousek J
    Comp Biochem Physiol C Toxicol Pharmacol; 2001 Jul; 129(3):175-91. PubMed ID: 11461835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onconase dimerization through 3D domain swapping: structural investigations and increase in the apoptotic effect in cancer cells.
    Fagagnini A; Pica A; Fasoli S; Montioli R; Donadelli M; Cordani M; Butturini E; Acquasaliente L; Picone D; Gotte G
    Biochem J; 2017 Nov; 474(22):3767-3781. PubMed ID: 28963346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of electrostatic interactions in the antitumor activity of dimeric RNases.
    Notomista E; Mancheño JM; Crescenzi O; Di Donato A; Gavilanes J; D'Alessio G
    FEBS J; 2006 Aug; 273(16):3687-97. PubMed ID: 16911519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ribonucleases as antiviral agents].
    Il'inskaia ON; Shakh Makhmud R
    Mol Biol (Mosk); 2014; 48(5):707-17. PubMed ID: 25842855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosolic RNase inhibitor only affects RNases with intrinsic cytotoxicity.
    Monti DM; D'Alessio G
    J Biol Chem; 2004 Sep; 279(38):39195-8. PubMed ID: 15277533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.
    Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ
    J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barnase and binase: twins with distinct fates.
    Ulyanova V; Vershinina V; Ilinskaya O
    FEBS J; 2011 Oct; 278(19):3633-43. PubMed ID: 21824291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human RNase 1 can extensively oligomerize through 3D domain swapping thanks to the crucial contribution of its C-terminus.
    Noro I; Bettin I; Fasoli S; Smania M; Lunardi L; Giannini M; Andreoni L; Montioli R; Gotte G
    Int J Biol Macromol; 2023 Sep; 249():126110. PubMed ID: 37536419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribonucleases as antiviral agents.
    Ilinskaya ON; Mahmud RS
    Mol Biol; 2014; 48(5):615-623. PubMed ID: 32214473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of cytotoxic ribonucleases by cationization to enhance intracellular protein delivery.
    Futami J; Yamada H
    Curr Pharm Biotechnol; 2008 Jun; 9(3):180-4. PubMed ID: 18673283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the track of antitumour ribonucleases.
    Benito A; Ribó M; Vilanova M
    Mol Biosyst; 2005 Oct; 1(4):294-302. PubMed ID: 16880994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribonucleases as potential modalities in anticancer therapy.
    Ardelt W; Ardelt B; Darzynkiewicz Z
    Eur J Pharmacol; 2009 Dec; 625(1-3):181-9. PubMed ID: 19825371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.
    Rutkoski TJ; Raines RT
    Curr Pharm Biotechnol; 2008 Jun; 9(3):185-9. PubMed ID: 18673284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural and engineered ribonucleases as potential cancer therapeutics.
    Arnold U; Ulbrich-Hofmann R
    Biotechnol Lett; 2006 Oct; 28(20):1615-22. PubMed ID: 16902846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody fusion proteins with human ribonucleases 1 to 8.
    Wezler X; Dübel S; Schirrmann T
    Hum Antibodies; 2018; 26(4):177-192. PubMed ID: 29689715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribonucleases and angiogenins from fish.
    Pizzo E; Buonanno P; Di Maro A; Ponticelli S; De Falco S; Quarto N; Cubellis MV; D'Alessio G
    J Biol Chem; 2006 Sep; 281(37):27454-60. PubMed ID: 16861230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crystal structure of the domain-swapped dimer of onconase highlights some catalytic and antitumor activity features of the enzyme.
    Gotte G; Campagnari R; Loreto D; Bettin I; Calzetti F; Menegazzi M; Merlino A
    Int J Biol Macromol; 2021 Nov; 191():560-571. PubMed ID: 34563576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A ribonuclease inhibitor resistant dimer of human pancreatic ribonuclease displays specific antitumor activity.
    Attery A; Dey P; Tripathi P; Batra JK
    Int J Biol Macromol; 2018 Feb; 107(Pt B):1965-1970. PubMed ID: 29042278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double domain swapping in bovine seminal RNase: formation of distinct N- and C-swapped tetramers and multimers with increasing biological activities.
    Gotte G; Mahmoud Helmy A; Ercole C; Spadaccini R; Laurents DV; Donadelli M; Picone D
    PLoS One; 2012; 7(10):e46804. PubMed ID: 23071641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.